CA2347085A1 - Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate - Google Patents

Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate Download PDF

Info

Publication number
CA2347085A1
CA2347085A1 CA002347085A CA2347085A CA2347085A1 CA 2347085 A1 CA2347085 A1 CA 2347085A1 CA 002347085 A CA002347085 A CA 002347085A CA 2347085 A CA2347085 A CA 2347085A CA 2347085 A1 CA2347085 A1 CA 2347085A1
Authority
CA
Canada
Prior art keywords
csg
levels
patient
cancer
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002347085A
Other languages
English (en)
Inventor
Shujath M. Ali
Yongming Sun
Susana Salceda
Herve Recipon
Robert Cafferkey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2347085A1 publication Critical patent/CA2347085A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne une méthode de détection, de diagnostic, de suivi, de classification par stade, de pronostic, de visualisation et de traitement de cancer de la prostate.
CA002347085A 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate Abandoned CA2347085A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10474198P 1998-10-19 1998-10-19
US60/104,741 1998-10-19
PCT/US1999/023764 WO2000023108A1 (fr) 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate

Publications (1)

Publication Number Publication Date
CA2347085A1 true CA2347085A1 (fr) 2000-04-27

Family

ID=22302121

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347085A Abandoned CA2347085A1 (fr) 1998-10-19 1999-10-18 Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate

Country Status (4)

Country Link
EP (1) EP1126877A4 (fr)
JP (1) JP2002527757A (fr)
CA (1) CA2347085A1 (fr)
WO (1) WO2000023108A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1466977A1 (fr) * 1999-03-08 2004-10-13 Genentech, Inc. Procédés et compositions pour l'inhibition de la croissance de cellules néoplastiques
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
CA2420193A1 (fr) * 2000-08-24 2002-02-28 Genentech, Inc. Compositions et procedes concus pour le diagnostic et le traitement de tumeur
NZ544911A (en) 2003-07-22 2008-12-24 Schering Ag RG1 antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (fr) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Homologues de f-spondine secretee

Also Published As

Publication number Publication date
JP2002527757A (ja) 2002-08-27
WO2000023108A1 (fr) 2000-04-27
EP1126877A1 (fr) 2001-08-29
EP1126877A4 (fr) 2003-05-28

Similar Documents

Publication Publication Date Title
US7858325B2 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6902892B1 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1109937B1 (fr) PROCEDE DE DIAGNOSTIC, DE SURVEILLANCE, DE CLASSIFICATION PAR STADES et D'IMAGERIE DE DIVERS CANCERS
US7326529B2 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000008210A1 (fr) Nouvelle methode permettant de diagnostiquer, de surveiller le cancer du sein, d'en determiner le stade ainsi que d'en former des images et de le traiter
US20050266483A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
WO2000023111A1 (fr) Methode permettant de diagnostiquer, de surveiller, de classer par stades, de visualiser et de traiter le cancer de la prostate
WO2001037779A2 (fr) Nouvelle methode de diagnostic, de surveillance, de stadification, d'imagerie et de traitement du cancer du sein
CA2347656A1 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
CA2347085A1 (fr) Methode de diagnostic, de suivi, de classification par stade, de visualisation et de traitement de cancer de la prostate
CA2345000A1 (fr) Nouveau procede pour diagnostiquer, surveiller, etablir la stadification, obtenir des images et traiter des cancers gastro-intestinaux
US6962779B1 (en) Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US6869592B1 (en) Method and antibody for imaging lung cancer
CA2346326A1 (fr) Nouveau procede de diagnostic, de controle, de stadification, d'imagerie et de traitement de cancers gynecologiques ou de cancers de la prostate
CA2345285A1 (fr) Nouveau procede pour diagnostiquer, controler, etablir le bilan d'extension, visualiser, et traiter des cancers gynecologiques
US6737040B1 (en) Method and antibody for imaging breast cancer
US20050106620A1 (en) Novel method of diagnosing, monitoring, staging, imaging and treating cancer
WO2000012761A1 (fr) Nouvel anticorps permettant de diagnostiquer le cancer de la vessie

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead